Repurposing Pomalidomide as a Neuroprotective Drug: Efficacy in an Alpha-Synuclein-Based Model of Parkinson's Disease.
Palmas MF, Ena A, Burgaletto C, Casu MA, Cantarella G, Carboni E, Etzi M, De Simone A, Fusco G, Cardia MC, Lai F, Picci L, Tweedie D, Scerba MT, Coroneo V, Bernardini R, Greig NH, Pisanu A, Carta AR.
Palmas MF, et al. Among authors: casu ma.
Neurotherapeutics. 2022 Jan;19(1):305-324. doi: 10.1007/s13311-022-01182-2. Epub 2022 Jan 24.
Neurotherapeutics. 2022.
PMID: 35072912
Free PMC article.